THERE'S A STORY that many people tell themselves about aging, and it goes something like this: As they get older, their physical health span declines precipitously when approaching the final decades of life
The pharmacological blockage of SGLT-1 with phloridzin, in a rat small intestine perfused system, results in just a halved secretion of GIP, GLP-1, or PYY, and the addition of phloretin, a GLUT2 inhibitor, brings these values down to basal levels
Conversely, for tirzepatide, the onset time was shorter in females than in males
These effects are typically mild to moderate and tend to diminish over time with continued use
However, it may not be suitable for everyone, and it's essential to consult with a doctor before starting any new medication, including Semaglutide
Increased injection frequency risks Each subcutaneous injection carries a small risk of infection, bruising, and tissue damage